SUPERNUS PHARMACEUTICALS, INC. Quarterly Unrecognized Tax Benefits in USD from Q4 2010 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Supernus Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2010 to Q4 2022.
  • Supernus Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2022 was $4.32M, a 29.1% decline year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $4.32M -$1.78M -29.1% Dec 31, 2022 10-K 2023-03-09
Q4 2021 $6.1M +$219K +3.72% Dec 31, 2021 10-K 2023-03-09
Q4 2020 $5.88M -$97K -1.62% Dec 31, 2020 10-K 2023-03-09
Q4 2019 $5.98M -$2.87M -32.4% Dec 31, 2019 10-K 2023-03-09
Q4 2018 $8.85M -$11K -0.12% Dec 31, 2018 10-K 2022-04-13
Q4 2017 $8.86M -$440K -4.73% Dec 31, 2017 10-K 2021-03-08
Q4 2016 $9.3M -$42K -0.45% Dec 31, 2016 10-K 2020-02-28
Q4 2015 $9.34M +$377K +4.21% Dec 31, 2015 10-K 2019-03-01
Q4 2014 $8.96M -$864K -8.79% Dec 31, 2014 10-K 2018-03-01
Q4 2013 $9.83M +$9.14M +1328% Dec 31, 2013 10-K 2017-03-16
Q4 2012 $688K -$64K -8.51% Dec 31, 2012 10-K/A 2017-01-20
Q4 2011 $752K +$110K +17.1% Dec 31, 2011 10-K 2015-03-12
Q4 2010 $642K Dec 31, 2010 10-K 2014-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.